Onconetix™ Chief Executive Officer Dr. Neil J. Campbell Issues Letter to Shareholders

CINCINNATI, Dec. 19, 2023 (GLOBE NEWSWIRE) -- Onconetix, Inc., (Nasdaq: BWV) ("Onconetix" or the “Company”) today issued the following shareholder letter from the Company’s Chief Executive Officer, Dr. Neil Campbell.

Read more at globenewswire.com